Ethypharm
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Bureaux De La Colline Bâtiment D 12ème 1...Phone Number
+33 141121720Website
www.ethypharm.comRevenue
<$5 MillionIndustry
About Ethypharm
Ethypharm Org Chart
Is Ethypharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Ethypharm is spiking on competitors!
Click to see if Ethypharm had a recent Job posting/layoffs
Product Launch: Get notified when Ethypharm launches new products
Check if Ethypharm has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Ethypharm has new funding data
Ethypharm, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Ethypharm recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Ethypharm
Recommended Actions
Reach out to Masked Content who joined Ethypharm as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Ethypharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ethypharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ethypharm.
Ethypharm Tech Stack
A closer look at the technologies used by Ethypharm
Most Recent Scoops
Ethypharm News & Media
ACQUISITION OF ARGATROBAN BUSINESS IN EUROPE
SAINT-CLOUD, France, June 17, 2024 /PRNewswire/ -- Ethypharm has entered into an agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to acquire the selective antithrombin agent, Argatroban monohydrate (Argatra®, Arganova®, Novastan®, Exembol®), in Europe. Ethypharm, known for its...Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China
SAINT-CLOUD, France, June 13, 2024 /PRNewswire/ -- Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate, Shanghai Ethypharm Pharmaceuticals Ltd, from the Chinese Company Jiangsu Anbison Pharmaceutical. Leader in essential medicines for central nervous system, hospital care and internal medicine, Ethypharm's strategy is to continue to grow in its key markets, the five major European Countries and China, as well as internationally with its sEthypharm announces the Appointment of Xavier LASSERRE as New Chief Commercial Officer
SAINT-CLOUD, France, June 13, 2023 /PRNewswire/ -- Denis DELVAL, President & CEO of the Ethypharm Group, announces the appointment of Xavier LASSERRE as Chief Commercial Officer (CCO), effective June 12, 2023. Xavier LASSERRE has a strong experience and expertise in the pharmaceutical...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ethypharm
Ethypharm is a European-based specialty pharmaceutical company with global reach and is committed to developing innovative drugs for the treatment of pain, addiction and critical care. Ethypharm develops and markets specialty drugs and generics that provide added value to healthcare providers and delivers high quality medicines for patients.... Read More